476 related articles for article (PubMed ID: 30325027)
21. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of residual or recurrent lymph nodes in the neck for patients with nasopharyngeal carcinoma after radiotherapy.
Wang M; Xu Y; Chen X; Chen H; Gong H; Chen S
J Cancer Res Ther; 2016; 12(2):909-14. PubMed ID: 27461673
[TBL] [Abstract][Full Text] [Related]
23. [Influence of level-Ib lymphadenopathy on the prognosis of nasopharyngeal carcinoma].
Yi W; Liu XM; Xia YF; Liu Q; Li JT
Chin J Cancer; 2010 Jan; 29(1):87-93. PubMed ID: 20038317
[TBL] [Abstract][Full Text] [Related]
24. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
Luo Y; Gao Y; Yang G; Lang J
Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
[TBL] [Abstract][Full Text] [Related]
25. Specific Selective Neck Dissection for Isolated Regional Failure in Nasopharyngeal Carcinoma after Radiation.
Wu JH; Xu JH; Ye F; Fu MY
Ear Nose Throat J; 2022 Nov; ():1455613221140280. PubMed ID: 36373511
[TBL] [Abstract][Full Text] [Related]
26. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: An analysis in 10,126 patients.
Zhang Y; Zhang ZC; Li WF; Liu X; Liu Q; Ma J
Oral Oncol; 2019 Aug; 95():150-156. PubMed ID: 31345383
[TBL] [Abstract][Full Text] [Related]
27. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].
Mao YP; Li WF; Chen L; Sun Y; Liu LZ; Tang LL; Cao SM; Lin AH; Hong MH; Lu TX; Liu MZ; Li L; Ma J
Ai Zheng; 2009 Oct; 28(10):1022-8. PubMed ID: 19799808
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.
Huang CL; Xu C; Zhang Y; Zhou GQ; Mao YP; Liu Q; Sun Y; Ma J; Tang LL
Radiat Oncol; 2018 Aug; 13(1):141. PubMed ID: 30081932
[TBL] [Abstract][Full Text] [Related]
29. Nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: clinical outcomes and patterns of failure among subsets of 8th AJCC stage IVa.
Huang CL; Guo R; Li JY; Xu C; Mao YP; Tian L; Lin AH; Sun Y; Ma J; Tang LL
Eur Radiol; 2020 Feb; 30(2):816-822. PubMed ID: 31650266
[TBL] [Abstract][Full Text] [Related]
30. Salvage treatment for isolated regional failure of nasopharyngeal carcinoma after primary radiotherapy.
Lo WC; Wang CP; Ko JY; Lou PJ; Yang TL; Wang CW; Hu YL; Chen TC
Ann Surg Oncol; 2012 Mar; 19(3):1001-8. PubMed ID: 21913020
[TBL] [Abstract][Full Text] [Related]
31. Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm.
Li YZ; Xie CM; Wu YP; Cui CY; Huang ZL; Lu CY; Wu PH
AJR Am J Roentgenol; 2015 Jan; 204(1):20-3. PubMed ID: 25539232
[TBL] [Abstract][Full Text] [Related]
32. Neck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma.
Yeung DCM; Yeung Z; Wong EWY; Vlantis AC; Chan JYK
Sci Rep; 2020 Mar; 10(1):5622. PubMed ID: 32221400
[TBL] [Abstract][Full Text] [Related]
33. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma.
Shi Q; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
Radiat Oncol; 2014 Jan; 9():7. PubMed ID: 24393418
[TBL] [Abstract][Full Text] [Related]
34. Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
Wu Z; Wang L; Xie DH; Lv SW; Su Y; Shi YR
Asia Pac J Clin Oncol; 2021 Aug; 17(4):330-337. PubMed ID: 33079493
[TBL] [Abstract][Full Text] [Related]
35. Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.
Chee J; Ting Y; Ong YK; Chao SS; Loh KS; Lim CM
Head Neck; 2016 Sep; 38(9):1393-400. PubMed ID: 27043448
[TBL] [Abstract][Full Text] [Related]
36. Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity-modulated radiotherapy.
Chen M; Tang LL; Sun Y; Mao YP; Li WF; Guo R; Liu LZ; Li L; Lin AH; Ma J
Head Neck; 2014 Apr; 36(4):468-73. PubMed ID: 23780916
[TBL] [Abstract][Full Text] [Related]
37. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
[TBL] [Abstract][Full Text] [Related]
38. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
39. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
[TBL] [Abstract][Full Text] [Related]
40. Salvage neck dissection for cervical recurrence of nasopharyngeal carcinoma.
Yen KL; Hsu LP; Sheen TS; Chang YL; Hsu MH
Arch Otolaryngol Head Neck Surg; 1997 Jul; 123(7):725-9. PubMed ID: 9236592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
